• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Metabolism . The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany

tetano

Editor, Senior Moderator
Metabolism


. 2020 Jul 13;154317.
doi: 10.1016/j.metabol.2020.154317. Online ahead of print.
The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany


Antonia Petersen[SUP] 1 [/SUP], Keno Bressem[SUP] 2 [/SUP], Jakob Albrecht[SUP] 2 [/SUP], Hans-Martin Thie?[SUP] 2 [/SUP], Janis Vahldiek[SUP] 2 [/SUP], Bernd Hamm[SUP] 2 [/SUP], Marcus R Makowski[SUP] 3 [/SUP], Alexandra Niehues[SUP] 2 [/SUP], Stefan Niehues[SUP] 2 [/SUP], Lisa C Adams[SUP] 4 [/SUP]



Affiliations

Abstract

Background and aims: Overall obesity has recently been established as an independent risk factor for critical illness in patients with coronavirus disease 2019 (COVID-19). The role of fat distribution and especially that of visceral fat, which is often associated with metabolic syndrome, remains unclear. Therefore, this study aims at investigating the association between fat distribution and COVID-19 severity.
Methods: Thirty patients with COVID-19 and a mean age of 65.6 ? 13.1 years from a level-one medical center in Berlin, Germany, were included in the present cross-sectional analysis. COVID-19 was confirmed by polymerase chain reaction (PCR) from nasal and throat swabs. A severe clinical course of COVID-19 was defined by hospitalization in the intensive care unit (ICU) and/or invasive mechanical ventilation. Fat was measured at the level of the first lumbar vertebra on routinely acquired low-dose chest computed tomography (CT).
Results: An increase in visceral fat area (VFA) by ten square centimeters was associated with a 1.37-fold higher likelihood of ICU treatment and a 1.32-fold higher likelihood of mechanical ventilation (adjusted for age and sex). For upper abdominal circumference, each additional centimeter of circumference was associated with a 1.13-fold higher likelihood of ICU treatment and a 1.25-fold higher likelihood of mechanical ventilation.
Conclusions: Our proof-of-concept study suggests that visceral adipose tissue and upper abdominal circumference specifically increase the likelihood of COVID-19 severity. CT-based quantification of visceral adipose tissue and upper abdominal circumference in routine chest CTs may therefore be a simple tool for risk assessment in COVID-19 patients.

Keywords: COVID-19; Obesity; Overweight; Quantification of adipose tissue; Visceral adipose tissue.
 
Back
Top Bottom